Detalle Publicación


Germline TP53 variants and susceptibility to osteosarcoma

Autores: Mirabello, L.; Yeager, M.; Mai, P.L.; Gastier-Foster, J.M.; Gorlick, R.; Khanna, C.; Patiño García, Ana; Sierrasesúmaga Ariznavarreta, Luis; Lecanda Cordero, Fernando; Andrulis, I.L.; Wunder, J.S.; Gokgoz, N.; Barkauskas, D.A.; Zhang, X.; Vogt, A. ; Jones, K.; Boland, J.F.; Chanock, S.J. ; Savage, S.A.
ISSN: 0027-8874
Volumen: 107
Número: 7
Páginas: djv101
Fecha de publicación: 2015
The etiologic contribution of germline genetic variation to sporadic osteosarcoma is not well understood. Osteosarcoma is a sentinel cancer of Li-Fraumeni syndrome (LFS), in which approximately 70% of families meeting the classic criteria have germline TP53 mutations. We sequenced TP53 exons in 765 osteosarcoma cases. Data were analyzed with ¿(2) tests, logistic regression, and Cox proportional hazards regression models. We observed a high frequency of young osteosarcoma cases (age <30 years) carrying a known LFS- or likely LFS-associated mutation (3.8%) or rare exonic variant (5.7%) with an overall frequency of 9.5%, compared with none in case patients age 30 years and older (P < .001). This high TP53 mutation prevalence in young osteosarcoma cases is statistically significantly greater than the previously reported prevalence of 3% (P = .0024). We identified a novel association between a TP53 rare variant and metastasis at diagnosis of osteosarcoma (rs1800372, odds ratio = 4.27, 95% confidence interval = 1.2 to 15.5, P = .026). Genetic susceptibility to young onset osteosarcoma is distinct from older adult onset osteosarcoma, with a high frequency of LFS-associated and rare exonic TP53 variants.